Y Li et al. showed that the expression of ADCY1 was downregulated in osteosarcoma compared with benign bone tumors, suggesting that ADCY1 may be potential biomarkers for osteosarcoma tumorigenesis and therapeutics50. The gene discussed is ADCY1; the disease is osteosarcoma.